|This Slide: #54 of 100|
Slide #54. STERIS Corporation — Integrated Medical Systems International, Inc.
STERIS Corporation (NYSE:STE)
Integrated Medical Systems International, Inc.
STERIS Corporation (NYSE:STE) today announced a definitive agreement to acquire Integrated Medical Systems International, Inc. (IMS) for a purchase price of approximately $165 million, plus approximately $10 million for the purchase of real estate. IMS, a privately held business, is an endoscope repair, surgical instrument management and sterile processing consulting company. IMS revenue for the current calendar year is anticipated to be approximately $150 million.
STERIS is a provider of infection prevention and other procedural products and services. Co. has four segments: Healthcare Products, which provides a portfolio of infection prevention, procedural and gastrointestinal solutions including consumable products, equipment maintenance and installation services; Healthcare Specialty Services, which provides a range of solutions and managed services including hospital sterilization services and instrument and scope repairs; Life Sciences, which designs, manufactures and sells consumable products, equipment maintenance, other services and capital equipment; and Applied Sterilization Technologies, which provides contract sterilization services.
STE SEC Filing Email Alerts Service
Open the STE Page at The Online Investor »
Buy (3.00 out of 4)
(ranked lower than approx. 66% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite